Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
41%
ALSO IN PINK
PINK
61
HOLDINGS
31%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus PINK)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in PINK |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.0% | 8.6% | 8.6% |
|
UNITEDHEALTH GROUP INC | 3.8% | 9.3% | 3.8% |
|
DANAHER CORP | 2.9% | 2.9% | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 3.2% | 2.3% | 2.3% |
|
AMGEN INC | 2.1% | 4.9% | 2.1% |
HRTS Overweight Relative to PINK
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.5% |
 |
ASTRAZENECA PLC | 4.8% |
|
MERCK & CO. INC. | 4.2% |
|
NOVARTIS AG | 3.6% |
|
JOHNSON & JOHNSON | 3.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
ABBOTT LABORATORIES | 2.6% |
 |
MEDTRONIC PLC | 2.4% |
|
GILEAD SCIENCES INC | 2.3% |
|
BRIDGEBIO PHARMA, INC. | 2.2% |
HRTS Underweight Relative to PINK
|
UNITEDHEALTH GROUP INC | -5.5% |
|
REGENERON PHARMACEUTICALS | -5.4% |
|
ALIGN TECHNOLOGY INC | -4.8% |
|
PURECYCLE TECHNOLOGIES INC | -4.7% |
|
APELLIS PHARMACEUTICALS, INC. | -3.9% |
|
JAZZ PHARMACEUTICALS PLC | -3.5% |
|
UNITED THERAPEUTICS CORP | -3.3% |
|
AMGEN INC | -2.8% |
|
WARBY PARKER, INC. CLASS A | -2.5% |
|
10X GENOMICS INC CLASS A | -2.3% |